Vaccines
Vaccines have long been a cornerstone of public health, effectively preventing infectious diseases and now expanding into cancer immunotherapy. With advancements in biotechnologies, modern vaccines utilize innovative platforms such as engineered vectors and extracellular vesicles to improve safety, efficacy, and delivery precision.
The integration of EVMed Group’s ExoCell™ Cell Development Platform elevates vaccine production to new heights by providing a GMP-grade system for high-yield engineered extracellular vesicle (EV) cell lines. This platform, powered by serum-free expression systems, ensures high-quality vaccine production with enhanced safety and scalability.